Related Experiment Video
Updated: Feb 24, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
Part 2: Pre-Clinical Assessment of Medical Displays for Regulatory Evaluation
Aldo Badano1, Wei-Chung Cheng1, Brendan J O'Leary1
1Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Bldg 62, Room 3116, Silver Spring, MD 20993; telephone 301/796-2534.
Regulatory assessment of medical image display systems faces challenges. This article reviews evidence for evaluating mobile, digital microscopy, and 3D medical displays.
Area of Science:
- Medical Imaging
- Display Technology
- Regulatory Science
Background:
- Pre-clinical assessment of medical image display systems presents evolving challenges.
- Evaluating diverse display technologies requires specific evidence-based approaches.
- Part 1 of this series introduced general concepts for medical display evaluation.
Purpose of the Study:
- To discuss emerging challenges in the regulatory assessment of medical image display systems.
- To outline relevant evidence for evaluating mobile image-viewing devices.
- To review evidence for true-color displays in digital microscopy and 3D medical displays.
Main Methods:
- Literature review of regulatory guidelines and scientific evidence.
- Analysis of assessment requirements for different display types.
- Discussion of evidence types relevant to display performance and clinical use.
Main Results:
- Specific challenges exist for mobile, digital microscopy, and 3D medical displays.
- Evidence requirements vary based on the display's intended application and technology.
- A framework for evaluating these systems is proposed based on current evidence.
Conclusions:
- Standardized pre-clinical assessment protocols are needed for advanced medical displays.
- Evidence generation must address the unique characteristics of mobile and specialized displays.
- Regulatory pathways need to adapt to the rapid evolution of medical imaging display technology.
More Related Videos
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
12:04Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
Related Concept Videos
Preclinical Development: Overview
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Clinical Trials: Overview